Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more
Global Health Limited (MEDANTA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.032x
Based on the latest financial reports, Global Health Limited (MEDANTA) has a cash flow conversion efficiency ratio of 0.032x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹858.20 Million) by net assets (₹26.54 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Global Health Limited - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Global Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Global Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Health Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tung Ho Steel Enterprise Corp
TW:2006
|
0.102x |
|
Papa John's International Inc
NASDAQ:PZZA
|
-0.093x |
|
Chongqing Zaisheng Tech Corp
SHG:603601
|
0.066x |
|
Genius Electronic Optical Co Ltd
TW:3406
|
0.069x |
|
Great Lakes Dredge & Dock
NASDAQ:GLDD
|
0.098x |
|
EVN AG
VI:EVN
|
-0.007x |
|
Pigeon Corporation
F:9N3
|
N/A |
|
Hypera S.A
SA:HYPE3
|
0.056x |
Annual Cash Flow Conversion Efficiency for Global Health Limited (2019–2025)
The table below shows the annual cash flow conversion efficiency of Global Health Limited from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹33.88 Billion | ₹6.24 Billion | 0.184x | -12.59% |
| 2024-03-31 | ₹29.06 Billion | ₹6.12 Billion | 0.211x | -20.64% |
| 2023-03-31 | ₹24.28 Billion | ₹6.45 Billion | 0.265x | +37.81% |
| 2022-03-31 | ₹16.16 Billion | ₹3.11 Billion | 0.193x | +10.13% |
| 2021-03-31 | ₹13.82 Billion | ₹2.42 Billion | 0.175x | +34.82% |
| 2020-03-31 | ₹13.50 Billion | ₹1.75 Billion | 0.130x | +11.84% |
| 2019-03-31 | ₹13.31 Billion | ₹1.54 Billion | 0.116x | -- |